MEMANTINE COMBINATIONS AND USE

• 收藏
• 分享

专利权人:

Chase Pharmaceuticals Corporation

发明人:

Kathleen E. CLARENCE-SMITH,Thomas N. CHASE

申请号：

US16723474

公开号：

US20200253893A1

申请日:

2019.12.20

申请国别(地区):

US

年份:

2020

代理人:

摘要：

A pharmaceutical combination of memantine and a non-anticholinergic antiemetic agent for the treatment of hypocholinergic disorders in further combination with high doses of donepezil and with solifenacin, and kits comprising said combination. A pharmaceutical combination of memantine and solifenacin for the treatment of hypocholinergic disorders, including Alzheimer type dementia, in further combination with high doses of donepezil, and kits comprising said combination.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/